193 related articles for article (PubMed ID: 21257717)
1. What do prostate cancer patients die of?
Riihimäki M; Thomsen H; Brandt A; Sundquist J; Hemminki K
Oncologist; 2011; 16(2):175-81. PubMed ID: 21257717
[TBL] [Abstract][Full Text] [Related]
2. Death causes in breast cancer patients.
Riihimäki M; Thomsen H; Brandt A; Sundquist J; Hemminki K
Ann Oncol; 2012 Mar; 23(3):604-610. PubMed ID: 21586686
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends in cause of death among Swedish and US men with prostate cancer.
Epstein MM; Edgren G; Rider JR; Mucci LA; Adami HO
J Natl Cancer Inst; 2012 Sep; 104(17):1335-42. PubMed ID: 22835388
[TBL] [Abstract][Full Text] [Related]
4. Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
Tendulkar RD; Hunter GK; Reddy CA; Stephans KL; Ciezki JP; Abdel-Wahab M; Stephenson AJ; Klein EA; Mahadevan A; Kupelian PA
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):94-9. PubMed ID: 23920389
[TBL] [Abstract][Full Text] [Related]
5. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.
Stattin P; Holmberg E; Johansson JE; Holmberg L; Adolfsson J; Hugosson J;
J Natl Cancer Inst; 2010 Jul; 102(13):950-8. PubMed ID: 20562373
[TBL] [Abstract][Full Text] [Related]
7. Use of statins and the risk of death in patients with prostate cancer.
Yu O; Eberg M; Benayoun S; Aprikian A; Batist G; Suissa S; Azoulay L
J Clin Oncol; 2014 Jan; 32(1):5-11. PubMed ID: 24190110
[TBL] [Abstract][Full Text] [Related]
8. Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.
Godtman RA; Holmberg E; Khatami A; Stranne J; Hugosson J
Eur Urol; 2013 Jan; 63(1):101-7. PubMed ID: 22980443
[TBL] [Abstract][Full Text] [Related]
9. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
Feuer EJ; Merrill RM; Hankey BF
J Natl Cancer Inst; 1999 Jun; 91(12):1025-32. PubMed ID: 10379965
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.
Rider JR; Sandin F; Andrén O; Wiklund P; Hugosson J; Stattin P
Eur Urol; 2013 Jan; 63(1):88-96. PubMed ID: 22902040
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.
Murtola TJ; Vettenranta AM; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
Eur Urol Focus; 2018 Dec; 4(6):851-857. PubMed ID: 28753870
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
13. Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis.
Sridhar G; Masho SW; Adera T; Ramakrishnan V; Roberts JD
Am J Mens Health; 2010 Sep; 4(3):189-206. PubMed ID: 20483872
[TBL] [Abstract][Full Text] [Related]
14. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Hugosson J; Carlsson S; Aus G; Bergdahl S; Khatami A; Lodding P; Pihl CG; Stranne J; Holmberg E; Lilja H
Lancet Oncol; 2010 Aug; 11(8):725-32. PubMed ID: 20598634
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer mortality in the Finnish randomized screening trial.
Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
J Natl Cancer Inst; 2013 May; 105(10):719-25. PubMed ID: 23479454
[TBL] [Abstract][Full Text] [Related]
16. Mortality causes in cancer patients with type 2 diabetes mellitus.
Liu X; Ji J; Sundquist K; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 May; 21(3):300-6. PubMed ID: 21960185
[TBL] [Abstract][Full Text] [Related]
17. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer".
Ablin RJ; Sartor O; Bennett CL
Arch Intern Med; 2010 Aug; 170(15):1397-9. PubMed ID: 20696969
[No Abstract] [Full Text] [Related]
18. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
[TBL] [Abstract][Full Text] [Related]
19. Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study.
Thorstenson A; Garmo H; Adolfsson J; Bratt O
J Urol; 2017 Jan; 197(1):61-66. PubMed ID: 27328367
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]